News & Updates

Implementation of a hospital-wide Alternatives to Opiates (ALTO) program falls short of reducing in-hospital or discharge opioid prescribing, reports a study.

Visits to the emergency department (ED) for suicide attempts and intentional self-harm have significantly increased from 2011 to 2020, as a proportion of total ED visits and as visits per capita, results of a US study have shown.

Adults suffering from persistent loneliness are likely to experience worse cognitive function and alterations in brain structure, suggests new evidence from the ongoing Whitehall II cohort study, presented at AAIC 2024.

Women with strong attachment to pets, especially dogs, are at lower risk of anxiety and depressive symptoms, according to a cross-sectional study.

Within families, reducing leisure-time screen media use over 2 weeks can yield positive benefits for the mental health of children and adolescents, according to a secondary analysis of a cluster randomized clinical trial.

New drug applications approved by US FDA as of 16-31 July 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.